We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Simple Blood Test Improves Heart Attack and Stroke Risk Prediction

By LabMedica International staff writers
Posted on 21 Apr 2025

Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. More...

High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart attacks, but they can also detect ongoing, unnoticed damage to the heart, which can indicate an increased risk of future cardiovascular disease. These tests can be administered alongside routine cholesterol tests during visits to general practitioners. Now, a new study has revealed that individuals with higher levels of troponin in their blood are at a greater risk of experiencing a heart attack or stroke within the next 10 years. The researchers' modeling suggests that, among individuals currently classified as being at intermediate risk during routine cardiovascular health assessments, these tests could prevent one heart attack or stroke for approximately every 500 individuals tested.

In the study conducted by the London School of Hygiene & Tropical Medicine (LSHTM, London, UK), the researchers analyzed anonymized health data from over 62,000 participants in 15 studies across Europe and North America. Troponin levels were measured along with conventional risk factors, such as age, blood pressure, diabetes history, smoking status, and cholesterol levels. The participants were followed for about 10 years to track whether they had a heart attack or stroke. Current cardiovascular health assessments typically use an algorithm to predict the likelihood of a heart attack or stroke within the next 10 years based on these risk factors, including cholesterol levels from blood tests. By incorporating troponin test results with these conventional risk factors, the study found that the algorithm's predictions were up to four times more accurate than when relying on cholesterol levels alone.

Importantly, the researchers’ modeling indicated that the troponin test was particularly effective in identifying risks in the 35 percent of people currently assessed as being at intermediate risk for cardiovascular problems. Individuals with a 2.5 percent to 15 percent chance of having a heart attack or stroke within 10 years are categorized as having intermediate risk. This group presents a challenge for medical professionals since their risk is too high for reassurance, but not high enough to warrant immediate preventative treatment. The modeling revealed that including the troponin test results reclassified up to 8 percent of people originally categorized as intermediate risk to high risk. Offering preventative treatments, such as statins, to these individuals could prevent numerous serious cardiovascular events, including heart attacks and strokes.

“Troponin, even in the normal range, is a powerful indicator of silent heart muscle damage. As such, the test provides an extra layer of information that we can use to boost our accuracy when predicting people’s risk. We want to identify as many high risk people as possible, so that no-one misses out on the opportunity to get preventative treatment,” said LSHTM Professor Anoop Shah, lead author of the study published in the Journal of the American College of Cardiology. “Incorporation of troponin into current cardiovascular risk estimation guidelines can be useful for identifying high risk individuals who will benefit from preventative treatment, reducing the risk of future circulatory problems.”


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.